Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
life sciences
national blog main
4
×
national
novartis
boston blog main
boston top stories
bristol-myers squibb
cancer drugs
cancer immunotherapy
new york blog main
new york top stories
samit hirawat
takeda pharmaceutical
abbvie
agios pharmaceuticals
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
david e. shaw
deals
detroit blog main
detroit top stories
diabetic macular edema
What
company’s
4
×
pipeline
4
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
corporation
diversity
hirawat
medical
myers
myers’s
officer
progress
scrip
spoke
squibb
trial
year
acquisitions
biggest
bio
build
buy
ceo
course
daniel
debut
development
discover
drug
dyne’s
experimental
gilead
growing
handiwork
Language
unset
4
×
Current search:
pipeline
×
company’s
×
" national blog main "
×
unset
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline